Thioredoxin reductase inhibitor auranofin prevents membrane transport of diphtheria toxin into the cytosol and protects human cells from intoxication
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft DFG (BA 2087/2-2)
- International Graduate School in Molecular Medicine Ulm
This publication has 41 references indexed in Scilit:
- Mechanism of Diphtheria Toxin Catalytic Domain Delivery to the Eukaryotic Cell Cytosol and the Cellular Factors that Directly Participate in the ProcessToxins, 2011
- Auranofin Protects against Anthrax Lethal Toxin-Induced Activation of the Nlrp1b InflammasomeAntimicrobial Agents and Chemotherapy, 2011
- Noble metal targeting of thioredoxin reductase — covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatinFree Radical Biology and Medicine, 2010
- Role of CypA and Hsp90 in membrane translocation mediated by anthrax protective antigenCellular Microbiology, 2010
- Thioredoxin and thioredoxin reductase: Current research with special reference to human diseaseBiochemical and Biophysical Research Communications, 2010
- The Cytotoxic Necrotizing Factors from Yersinia pseudotuberculosis and from Escherichia coli Bind to Different Cellular Receptors but Take the Same Route to the CytosolInfection and Immunity, 2007
- Membrane translocation of diphtheria toxin A-fragment: role of carboxy-terminal regionBiochemistry, 1993
- Elimination of the disulphide bridge in fragment B of diphtheria toxin: effect on membrane insertion, channel formation, and ATP bindingMolecular Microbiology, 1991
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Diphtheria Toxin Submit Active in vitroScience, 1969